TransOral Robotic Surgery (TORS) is the world's first group of minimally invasive robotic surgery techniques that enable Penn surgeons to remove benign and malignant tumors of the mouth and throat.
Video: A Celebration of the FDA Approval of TransOral Robotic Surgery (TORS)
The video was taken at an event that was held to celebrate the FDA approval of TransOral Robotic Surgery (TORS), a minimally invasive surgical approach that was developed by head and neck surgeons at Penn Medicine.
Today, TORS at Penn Medicine is a world-class surgical program comprised of leading surgeons, anesthesiologists, nurses, and clinicians dedicated to providing superior patient outcomes through the use of robotic-assisted technology. The program benefits patients seeking state-of-the-art care, but also educates physicians who come from around the world to observe and learn about this groundbreaking procedure.
Along with performing all of the original research, Penn Medicine was the first medical center in the world to offer TORS in 2005.
TORS is an exceptional example of how Penn surgeons have taken a clinical breakthrough from “bench to bedside,” providing patients with the best possible care.